Physician

Daniel Jiangdan Zhou, MD

According to 2025 Medicare claims, Daniel Zhou, MD (NPI: 1982264917) practices epileptologists in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1164810271; TIN: 232743545) and primary practice location at 19104-4208.

Zhou's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 36 traditional Medicare patients, billed 55 HCPCS/CPT codes, and received $5,055 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 70 prescription claims across 19 beneficiaries totaling $5,935 in drug costs, led by Lacosamide (Lacosamide). Open Payments data shows 2 records totaling $249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,382 to $5,935. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5K$5.1K2024 Medicare payment: $5,055 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20243655$5,055

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.0K$5.9K2020 Drug cost: $3,382 (USD; Tot_Drug_Cst)2021 Drug cost: $1,734 (USD; Tot_Drug_Cst)2022 Drug cost: $775 (USD; Tot_Drug_Cst)2023 Drug cost: $702 (USD; Tot_Drug_Cst)2024 Drug cost: $5,935 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201333$3,382
2021N/R42$1,734
2022N/R24$775
2023N/R14$702
20241970$5,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional1216$166
95816Measurement of brain wave activity (eeg), awake and drowsy1515$44

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LacosamideLacosamide11585$1,929
LevetiracetamLevetiracetam20863$441
LamotrigineLamotrigine11330$385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$249JAZZ PHARMACEUTICALS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Jiangdan Zhou, MD?

Tedicare shows public-source Medicare data for Daniel Jiangdan Zhou, MD (NPI 1982264917), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Jiangdan Zhou, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Jiangdan Zhou, MD?

Daniel Jiangdan Zhou, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1164810271) in the available physician profile data.

Does Daniel Jiangdan Zhou, MD have Open Payments data?

Daniel Jiangdan Zhou, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.